Results 271 to 280 of about 14,156,764 (395)

Selected risk factor analysis for coalbed methane development with optimized fuzzy based knowledge mapping at Jamalganj coalfield in Bangladesh. [PDF]

Sci Rep
Zhang J, Miah MH, Al MA.
europepmc   +1 more source

Providing Seasonal-to-Interannual Climate Information for Risk Management and Decision-making

, 2010
Lisa Goddard, Youcef Ait‐Chellouche, Walter Baethgen, Michael D. Dettinger, Richard Graham, Peter Hayman, M. Ait Kadi, Rodney Martínez, Holger Meinke   +8 more
openalex   +1 more source

Migraine in Postmenopausal Women and the Risk of Invasive Breast Cancer [PDF]

, 2008
Robert Mathes, Kathleen E. Malone, Janet R. Daling, Scott Davis, Sylvia Lucas, Peggy L. Porter, Christopher I. Li   +6 more
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Transnistrian economy: initiatives and risks [PDF]

, 2003
Gudym, Anatoly, Kutyrkin, Vladislav et al   +1 more
core  

Cumulative risk communication: comparing practitioner perspectives with public interpretation and response. [PDF]

BMC Public Health
Ripberger J, Gupta K, Jenkins-Smith H, Rosen Z, Meister E, Fox A.   +5 more
europepmc   +1 more source

New advances in DPYD genotype and risk of severe toxicity under capecitabine

, 2017
Marie-Christine Étienne-Grimaldi, Jean-Christophe Boyer, Christophe Béroud, Litaty Mbatchi, André B. P. Kuilenburg, Christine Bobin‐Dubigeon, Fabienne Thomas, Étienne Chatelut, Jean‐Louis Merlin, Frédéric Pinguet, Christophe Ferrand, Judith Meijer, Alexandre Evrard, Laurence Llorca, Gilles Romieu, Philippe Follana, Thomas Bachelot, L. Chaigneau, Xavier Pivot, Véronique Dièras, Rémy Largillier, Mireille Mousseau, Anthony Gonçalves, Henri Roché, Jacques Bonneterre, V. Servent, Nadine Dohollou, Y. Château, Emmanuel Chamorey, Jean‐Pierre Desvignes, David Salgado, Jean-­Marc Ferrero, G. Milano   +32 more
openalex   +2 more sources

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source

Preconception health risk profiles among women planning pregnancy in northern Ethiopia: a latent class analysis. [PDF]

BMJ Open
Gebretsadik GG, Biratu AK, Kahsay AB, Mulugeta A, Gessessew A, S Lassi Z.   +5 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source